Whois & Analysis for clearblue.com

A fertility monitor is an electronic device which may use various methods to assist the user with fertility awareness.

A fertility monitor may analyze changes in hormone levels in urine, basal body temperature, electrical resistance of saliva and vaginal fluids, or a combination of these methods.

These devices may assist in pregnancy achievement.

Ovulation is the release of egg from the ovaries.

In humans, this event occurs when the de Graaf's follicles rupture and release the secondary oocyte ovarian cells.

After ovulation, during the luteal phase, the egg will be available to be fertilized by sperm.

In addition, the uterine lining (endometrium) is thickened to be able to receive a fertilized egg.

If no conception occurs, the uterine lining as well as blood will be shed during menstruation.

Clearblue is the flagship brand of SPD Swiss Precision Diagnostics GmbH and offers consumer home diagnostic products such as pregnancy tests, ovulation tests and fertility monitors.

The Clearblue brand is distributed in 47 countries and was first launched in United Kingdom in 1985.

A pregnancy test attempts to determine whether a woman is pregnant.

Markers that indicate pregnancy are found in urine and blood, and pregnancy tests require sampling one of these substances.

The first of these markers to be discovered, human chorionic gonadotropin (hCG), was discovered in 1930 to be produced by the syncytiotrophoblast cells of the fertilised ova (eggs).

While hCG is a reliable marker of pregnancy, it cannot be detected until after implantation: this results in false negatives if the test is performed during the very early stages of pregnancy.

Obstetric ultrasonography may also be used to detect pregnancy.

Obstetric ultrasonography was first practiced in the 1960s; the first home test kit for hCG was invented in 1968.

The kits went on the market in the United States and Europe in the mid-1970s.